The Anne and Joel Ehrenkranz Laboratory for the Study of Human Resilience is an integral entity within the Depression and Anxiety Center for Discovery and Treatment. Our mission is to drive scientific discovery aimed at understanding the nature of human resilience and how resilience can be enhanced to prevent or treat common and disabling mental disorders including depression, anxiety, and post-traumatic stress disorder (PTSD).
Specifically, we aim to:
- Define brain systems in humans that regulate the response to stress, and understand how these systems differ between healthy individuals and those suffering from stress-related disorders.
- Identify new biological or behavioral processes that create resilience to stress or that enhance the maladaptive consequences of stress.
- Test novel interventions that protect against the negative effects of stress and treat common stress-related disorders including depression, anxiety, and PTSD.
Our team of researchers in basic neuroscience and clinical psychiatry explores mood disorders and resilience with the shared goal of developing new and improved treatment options. From psychotherapy techniques to pharmaceutical strategies and device-based therapies, the Ehrenkranz Laboratory is home to pioneering work that will shape the future of the field.